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ABSTRACT  
 
Clara cells of mammalian airways have multiple functions and are morphologically 
heterogeneous. While Notch signaling is essential for the development of these cells, it is unclear 
how Notch influences Clara cell specification and if diversity is established among Clara cell 
precursors. Here we identify expression of the secretoglobin Scgb3a2 and Notch activation as 
early events in a program of secretory cell fate determination in developing murine airways. We 
show that Scgb3a2 expression in vivo is Notch-dependent at early stages, is ectopically induced 
by constitutive Notch1 activation, and that in vitro Notch signaling together with the pan-airway 
transcription factor Ttf1 (Nkx2.1) synergistically regulate secretoglobin gene transcription. 
Furthermore, we identified a novel subpopulation of secretory precursors juxtaposed to 
presumptive Neuroepithelial Bodies (NEBs), distinguished by their strong Scgb3a2 and 
Uroplakin3A (Upk3a) signals and reduced Ccsp (Scgb1a1) expression. Their association with 
NEBs is crucial, since genetic disruption of Ascl1 prevented NEB formation and selectively 
interfered with formation of this subpopulation of cells. Lineage labeling of Upk3A-expressing 
cells during development showed that these cells remain uncommitted during embryonic 
development and contribute to Clara and ciliated cells in the adult lung. Together our study 
suggests a role for Notch in the induction of a Clara cell-specific program of gene expression and 
reveals that the NEB microenvironment in the developing airways is a niche for a distinct subset 
of Clara-like precursors.  
    3
\body 
INTRODUCTION 
 
The airways of the mammalian lung are populated by distinct epithelial cell types 
distinguished by their morphology and expression of molecular markers. Clara and ciliated cells 
are the most abundant while basal and neuroendocrine (NE) cells are restricted in number and 
distribution (1). Clara cells synthesize components of the airway lining fluid, mediate 
mucociliary clearance in concert with ciliated cells, and metabolize environmental toxins. 
Furthermore, they act as facultative progenitor cells during lung injury-repair (1-3).  
Clara cells in the mouse lung have been distinguished in molecular terms by the 
expression of the secretoglobin Scgb1a1/Clara cell secretory protein (Ccsp or CC10). 
Subpopulations of Clara cells with distinctive morphology and susceptibility to environmental 
exposures have been reported in the mouse lung and in other species (4). For example, 
ultrastructural analysis of conducting airways shows that Clara cells surrounding clusters of 
neuroepithelial cells (neuroepithelial bodies, NEBs) have a distinct flattened morphology (5). 
These cells are also functionally distinct from other Clara cells as they are deficient in the 
cytochrome P450 enzyme Cyp2f2 (6). It is thought that the absence of Cyp2f2 renders resistance 
to Naphthalene injury (6).  
Genetic studies in mice demonstrate an essential role for the Notch signaling in the 
specification of Clara cells during lung development (7, 8). The Notch pathway is a juxtacrine 
signaling system that regulates cell fate choices in multiple biological systems (9-11). The 
pathway is activated by the binding of transmembrane Notch receptors (Notch1-4) and 
transmembrane ligands Delta-like (Dll1, 3, 4) or Jagged (Jag1, Jag2).  Ligand- receptor 
interaction results in gamma-secretase-dependent cleavage of the cytoplasmic domain of the 
Notch receptor. Nuclear translocation and interaction of this cleaved intracellular domain 
(NICD) with the Rbpjk transcriptional complex then leads to activation of a canonical pathway 
and the expression of target genes.  Developing airways that are deficient in Rbpjk  or Protein O-
fucosyltransferase-1 (Pofut1), an enzyme required for the efficient  binding of Notch receptor to 
ligand, lack Clara cells and have supernumerary ciliated cells (7, 8). Conversely, constitutive 
activation in the developing lung epithelium results in mucous metaplasia and in a decrease in 
numbers of ciliated cells (12). 
Studies of the mechanisms of Clara cell specification and the role of Notch signaling 
therein have been limited by the paucity of early markers of differentiation. Transcription factors 
that label ciliated (Foxj1), neuroendocrine (Ascl1) and basal (Trp63) progenitors are known. 
However, with the exception of NICD, no nuclear factor specific to Clara cell progenitors has 
been identified. Hes1, a Notch transcriptional target, is expressed in developing airways, 
including Clara precursors, but it is not required for the specification of Clara cells (13). 
Secretoglobins are a family of small, secreted, structurally similar disulfide-linked dimers of 
which three members, Ccsp (Scgb1a1), Scgb3a1 and Scgb3a2 are expressed in Clara cells in the 
lung (14). At present, the secretoglobin Ccsp is the only definitive marker for Clara cells. 
Markers like Trp63, Ascl1 and Foxj1 have been localized to the developing airways E12.5 
onwards. In contrast, Ccsp expression has been observed from E15.5 onwards (14).  
Here we examine the early events associated with the induction of Clara cell fate and the 
contribution of developmental programming in establishing differences among Clara cells in the 
mouse airway epithelium. We identify Scgb3a2 and activated Notch as markers of an early 
program of Clara cell fate. Moreover, we implicate Notch as a mediator of a Clara cell-specific   4
program of gene expression in airway epithelial precursors. This program is modified in the 
developing NEB microenvironment to generate a distinct subpopulation of Clara cell precursors.  
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RESULTS 
 
Notch activation in the developing airways precedes expression of known markers of 
airway differentiation.  
Lineage analysis of cells that experienced Notch1 activation in the developing airways 
and loss-of-function genetic studies have shown that Notch signaling correlates with and is 
essential for the Clara cell fate (7, 8).  To characterize the spatio-temporal regulation of Notch 
signaling in the developing airways we examined the distribution of activated Notch1 by 
immunohistochemistry (IHC) using an antibody against cleaved Notch1 (hereafter NICD) (7). 
NICD labeling was first detected in the respiratory epithelium at E12.5, at low levels, and 
restricted to the trachea and main bronchi (Fig. 1A,B). At E14.5 NICD-positive cells were more 
abundant in the proximal airways but absent in the distal airways (Fig. 1C-E).  At this stage 
strong NICD signals were detected in clusters occupying a relatively apical position within the 
pseudo-stratified epithelium in proximal intrapulmonary airways (Fig.1E,F). This contrasted with 
lower intensity and more homogenous pattern of NICD labeling outside the clusters. The 
expression in clusters was reminiscent of the distribution of Ascl1 (mouse achaete-scute complex 
homologue 1, Mash1), a bHLH transcription factor essential for NE cell fate and a marker for 
presumptive neuroepithelial bodies (pNEBs) (15). Double IHC confirmed the presence of the 
NICD clusters juxtaposed to and distinct from Ascl1-expressing cells (Fig. 1F). At this stage 
most, if not all, clusters of NICD were juxtaposed to pNEBs. By E18.5 NICD was detected 
throughout the airway epithelium and in clusters associated with pNEBs. (Fig. 1G). Previous 
studies have suggested that Ascl1 (E13.5) is the earliest marker for airway differentiation (15). 
We conclude that Notch signaling is activated in the developing airway epithelium prior to any 
of the known markers of differentiation and is activated around pNEBs from early stages. 
 
NEB-associated cells show distinct phenotypic features during development suggestive of a 
subpopulation of Clara cell precursors 
  The early onset of Notch activation in the developing lung suggested that the 
determination of the Clara cell fate initiates earlier than the expression of Ccsp and led us to 
search for early markers. Previous studies showed that Scgb3a2, another member of the 
secretoglobin gene family, is also expressed in secretory Clara cells of developing airways (8, 
14, 16, 17).  This led us to investigate whether Scgb3a2 correlates with Notch activation at early 
stages. In situ hybridization (ISH) revealed Scgb3a2 expression from E12.5 onwards; expression 
was localized to the trachea and extrapulmonary bronchi (Fig. 2A). Scgb3a2 expression became 
stronger and expanded to lobar bronchi at E13.5-14.5 and was widespread by E18.5 (Fig. 2.B-D). 
At E14.5 Scgb3a2 was strongly expressed in clusters of cells in proximal airways (Fig.2C). 
Double ISH-IHC and confocal analysis of E14.5 lungs confirmed co-localization of Scgb3a2 and 
NICD (Fig. 2E). Co-localization was not restricted to these cell clusters but was harder to detect 
elsewhere in the epithelium due to the weaker NICD signals.  
We tested whether clusters of Scgb3a2 positive cells were arising at sites of Ascl1-
expressing cells, as seen for NICD. Sections from E13.5 –E18.5 lungs were labeled with a 
Scgb3a2 riboprobe and an anti Ascl1 antibody. At E14.5, Scgb3a2 signals were present in the 
expected uniform and clustered patterns (Fig. 2F); 70-80% of the Scgb3a2-expressing clusters 
were associated with the Ascl1-expressing cell clusters.  Confocal microscopy confirmed that 
cells expressing Scgb3a2 or Ascl1 were distinct and in direct contact. (Fig. 2G). Interestingly,   6
analysis of E13.5-E14.5 lungs showed a P-D pattern of pNEB formation in intrapulmonary 
airways, preceding the local appearance of Scgb3a2 (Fig. 2H).  
These data show that the pNEB-microenvironment at E14.5 consists of clusters of Ascl1-
expressing cells and another cell population expressing high levels of NICD and Scgb3a2. No 
Foxj1 labeling was detected in these cells at any of the stages studied. Therefore, we 
hypothesized that the NEB microenvironment is a niche for Clara cell precursors and examined 
the distribution of Ccsp in the NEB microenvironment at E18.5. However, simultaneous labeling 
of NICD/Ccsp/Ascl1 at E18.5 demonstrated that cells clustered around NEBs had high levels of 
NICD but low to negligible levels of Ccsp (Fig. 2I-O) Three-color labeling of Scgb3a2 
(ISH)/Ccsp (ISH)/Cgrp (IHC) (Calcitonin gene-related peptide, another NE cell marker) 
confirmed that cells in the pNEB microenvironment continue to express Scgb3a2 at this stage 
and have low to negligible levels of Ccsp. Our data suggested that cells associated with NEBs 
are a distinct set of Clara cell progenitors. 
 
High levels of Uroplakin 3A (Upk3a) expression distinguishes secretory precursors in the 
NEB microenvironment 
  The absence of secretory cells in the airways of Notch signaling-deficient mice presented 
a unique opportunity to screen for additional markers enriched in the developing Clara cells. 
Thus, we compared the global gene expression profile of E18.5 lungs from control and mutant 
mice in which the Rbpjk gene was disrupted in the airway epithelium (Shh-Cre;Rbpjk
Flox/Flox, or 
Rbpjk 
cnull)(18). As expected, genes associated with the Clara cell phenotype, such as Ccsp, 
Scgb3a2 and Cyp2f2 were expressed at significantly higher levels in control lungs (Fig. 3A). A 
comprehensive description of this screen will be reported elsewhere. Importantly, this screen 
identified Uroplakin 3a (Upk3a, Fig. 3A) as a putative marker of Clara precursors. Upk3a 
encodes a single-pass transmembrane domain-containing protein of the Uroplakin family that is 
expressed in the urinary bladder epithelium (19, 20). Mice deficient in Upk3a have compromised 
urothelial permeability but no phenotype has been described in the lung(19).  
We examined Upk3a expression in control and Rbpjk 
cnull mice by ISH (Fig. 3B,C). In 
E18.5 controls Upk3a was highly enriched in cell clusters in the proximal airways, although 
signals could be also detected at lower levels in scattered cells in the distal airway epithelium 
(Fig. 3B, bracket). This differed from the widespread expression patterns of Scgb3a2 and Ccsp at 
E18.5 (Fig. 2). Upk3a signals were undetectable in airways of Rbpjk 
cnull mice (Fig. 3C). 
Developmental analysis of Upk3a expression using ISH and quantitative Real-time PCR 
(qPCR) detected signals at E12.5 (qPCR) and 14.5 (ISH), and showed increasing levels 
thereafter (Fig. 3D-F). ISH revealed clustered distribution from early stages and prompted us to 
investigate the relationship of Upk3a-expressing cells with pNEBs. Double ISH (Upk3a)/IHC 
(Ascl1) showed that Upk3a-expressing cells were juxtaposed to the Ascl1-labeled clusters from 
the earliest stages (Fig.3E-F).  Quantitative analysis showed that between 70-80% of pNEBs at 
E14.5 were associated with Upk3a clusters. Next we investigated whether Upk3a-expressing 
cells were present in the NEB microenvironment in the adult lung. Double ISH/IHC using a 
Upk3a-riboprobe and an anti-Cgrp antibody showed at least 1-5 Upk3a-expressing cells in 
association with 50% of all NEBs examined (Fig. 3G).   
 Since  Cyp2f2 has been reported as marker for Clara cells (17) and was also identified by 
our expression profiling as downregulated in Notch-deficient airways, we characterized its 
developmental pattern of expression.  ISH showed Cyp2f2 expression throughout the epithelium 
of the trachea and extrapulmonary airways from E13.5 and expanded to distal airways at later   7
times (Suppl.Fig.1A,B). To determine the spatial relationships among Scgb3a2, Upk3a, Cyp2f2 
and pNEBs, serial sections were labeled with these riboprobes and subsequently stained with an 
anti-Ascl1 antiserum. Analysis of E14.5 lungs showed that the pNEB-associated cell clusters that 
typically express strong Scgb3a2 and Upk3a signals, had little, if any, Cyp2f2 (Suppl. Fig.1C-E). 
This contrasted with the strong Cyp2f2 signals in neighboring Scgb3a2 positive cells. At E18.5 
this subpopulation could be distinguished by strong Upk3a but not by low Cyp2f2 expression as 
seen at earlier times (Suppl. Fig. 1F).  
 
The NEB microenvironment harbors a subset of Clara cell precursor in developing airways   
Next we asked whether the features identified in the pNEB-associated cells were 
dependent on the pNEBs. Previous studies show that neither solitary NE cells nor NEBs form in 
Ascl1 null mice (13, 15). Given the small numbers of cells in the pNEB microenvironment and 
paucity of specific markers for these cells, we reasoned that the ablation of these cells would 
have escaped detection and reexamined the Ascl1 null mice. Analysis of these mutants at E14.5 
showed that, in the absence of pNEBs, the clustered expression of NICD and Scgb3a2 was 
abolished, although the weak, non-clustered signals remained in proximal airways (Suppl. Fig. 
2A-D). At E18.5, the strong expression of NICD and Scgb3a2 throughout the airway epithelium 
did not allow distinguishing differences between control and Ascl1 mutants.  
We then investigated the impact of Ascl1 deletion on Upk3a. No Upk3a-labeled cell 
clusters were detected in Ascl1 null mutant lungs at E14.5 or E18.5 (Fig.3H-K).  The selective 
loss of the Upk3a-labeled cell clusters was further supported by the presence of Upk3a signals in 
other structures (esophagus: Fig. 3I) or in the scattered cells outside the NEB microenvironment 
(Fig. 3K, inset) in Ascl1 mutants. The local impact of pNEB described here is agreement with 
the loss of SSEA-1-expressing cells in Ascl1 null mutants reported in the co-submitted 
manuscript by Morimoto et al. The Ascl1 phenotype contrasts with the generalized disruption of 
Upk3a that we found in the airways of Rbpjk 
cnull mice (Fig. 3C). qPCR showed that Upk3a 
mRNA is abolished in Rbpjk 
cnull  lungs both at E14.5 and E18.5 (Fig. 3L). The observation is 
consistent with the inability to form Clara cells upon disruption of Notch signaling.  In Ascl1 
null mice, Upk3a expression was also markedly downregulated at E14.5 but only marginally 
decreased at 18.5 (Fig. 3L). The more dramatic reduction in Upk3a transcripts seen at E14.5 
mutants was expected since at this stage Upk3a-expressing cells formed essentially around 
pNEBs. Later, the contribution of non-pNEB associated cells minimized the differences in 
Upk3a expression between control and Ascl1 mutants (see also Suppl. Fig.2 E-G for Scgb3a2). 
These results suggest that NEBs are required to induce if not maintain a population of cells 
expressing high levels of Upk3a in its microenvironment.  
The identification of Upk3a as a marker enriched in pNEB microenvironment provided 
us with an opportunity to examine the fate of these cells. We investigated the fate of Upk3a-
expressing cells in the airways during prenatal and adult life using an Upk3aCreER
T2 transgenic 
mouse. A single dose of Tamoxifen (see methods, Figure 4A) was administered to Upk3aCre 
ER
T2;Rosa26lacZ  dams 15.5 days post coitum. Offspring were analyzed at E18.5 and at 
postnatal day 60.  As putative Clara cell precursors, we investigated the ability of Upk3aCre-
labelled cells to give rise to Clara and ciliated cells (2).  Thus, we performed double IHC/Xgal 
staining using antibodies against Foxj1, βTubulin IV (ciliated), and Ccsp, followed by 
quantitative analysis. (Fig.4). At E18.5, while lacZ signal was detected in a small number of 
cells, few were double labeled with Ccsp and only a single cell was double-labeled with Foxj1. 
This showed that Upk3a lineage was largely uncommitted to either Clara or ciliated fates at this   8
stage and was consistent with our IHC/ISH studies. By contrast, analysis of adult lungs showed 
labeling in both ciliated and Clara cells at nearly similar proportion (Ccsp: 47.2 + 3.4%.; 
βTubulin: 45.3 + 4.0%) (Fig.4 J,K).  The pool of cells that are lacZ positive, Ccsp negative and 
lacZ positive, βTubulin negative may include cells that remained undifferentiated even in adults. 
Lineage-labeled cells were distributed throughout the airway epithelium and only a few of these 
cells were apposed to PNECs (Fig.B-G). Analysis using the NE marker PGP9.5 showed no 
colocalization with lacZ (total of 69 lacZ positive cells examined). Together our data suggest that 
during development the pNEB microenvironment harbors a population of less mature Clara cell 
precursors with equal potential to become Clara or ciliated cell (see discussion). 
 
Notch signaling regulates expression of Scgb3a2, Upk3a and Ccsp by a transcriptional 
mechanism   
To gain further insights into the mechanisms by which Notch signaling regulates gene 
expression in Clara progenitors, we examined the effect of loss or gain of Notch function on 
expression of genes at early stages, prior to the onset of Ccsp expression. We generated mice in 
which Notch signaling was disrupted (Rbpjk
cnull)(18)) or constitutively activated in the lung 
epithelium using ShhCre and Rosa-NICD transgenes(12). Analysis of the Scgb3a2 pattern in 
E14.5 Rbpjk
cnull lungs showed marked downregulation in extrapulmonary airways and negligible 
signals in intrapulmonary airways, including the cells in the pNEB microenvironment, which 
normally express strong Scgb3a2 (Fig 5A-B; Fig.2).  In contrast, E14.5 ShhCreNICD mice 
showed widespread expression of Scgb3a2 in the airway progenitors (Fig. 5E). Upk3a expression 
was similarly modulated by Notch signaling (Fig. 5B, F). Interestingly, we did not detect 
expression of the late marker Ccsp in E14.5 lungs overexpressing NICD, but strong signals were 
present at E18.5 (Suppl.Fig. 3A, B). As evidenced by the morphology, NICD overexpression led 
to aberrantly enlarged airways. Nevertheless, these airways retained respiratory identity as they 
expressed Ttf1 (Fig.5C-D).  
Based on the genetic data above and our evidence establishing Scgb3a2 as an early Clara 
marker, we investigated whether Notch could directly regulate Scgb3a2 transcription.  A screen 
for Rbpjk binding sites 1kb region upstream to the Transcription Start Site (TSS) of the murine 
Scgb3a2 promoter revealed high (YGTGRGAA) and low (RTGRGAR) affinity binding sites 
(Fig.5G)(21-23). For subsequent analysis we focused on the putative high affinity binding site. 
We performed electrophoretic mobility shift analysis (EMSA) using COS-1 cell nuclear extracts 
and oligonucleotides containing the Rbpjk high affinity binding sequence (intact, mutated);   
COS-1 cells are known to endogenously express Rbpjk (24). Detection of a DNA-protein band 
that was supershifted with an anti-Rbpj antibody confirmed that endogenous Rbpjk can bind to 
this site (Fig.5H). Next, we performed luciferase reporter assays using Scgb3a2 promoter 
sequences -273 bp to the TSS containing either a control (WT) or a mutated Rbpjk high affinity 
site. Co-transfection with an NICD-containing plasmid resulted in minimal induction of reporter 
activity (<2-fold). This response was similar to that elicited by cotransfection of the same 
construct with an expression plasmid-containing Ttf1, a known transcriptional regulator of 
Scgb3a2. We conclude that despite the presence of a high affinity binding site in the promoter 
fragment, NICD expression is insufficient to induce reporter expression (Fig. 5I). 
Interactions between Notch and other transcription factors have been implicated in the 
control of gene expression during development (21, 25). Moreover, synergistic regulation of the 
mouse Scgb3a2 gene by Ttf1 and other transcription factors, such as C/EBP has been previously 
reported (26). We tested the possibility that NICD could act in concert with Ttf1 to transactivate   9
the Scgb3a2 promoter (Fig.5I).  Co-expression of Ttf1 and NICD dramatically increased reporter 
activity (over 40 fold). Importantly, introducing a mutation in the Rbpjk high affinity site 
(TTCTCACG to TTGTCTCG) nearly abolished this synergistic interaction (Fig.5I).  
We extended our promoter analysis to other Clara cell-associated genes like Upk3a and 
Ccsp. Both genes have multiple Rbpjk and Ttf1 binding sites in their promoters (Suppl. Fig4 
and5). Reporter assays showed that both Upk3a and Ccsp and were transactivated by NICD and 
Ttf1 in a synergistic manner, as observed for Scgb3a2 (Suppl. Figs 4 and 5). Together, our data 
suggests a model in which Notch, in conjunction with locally expressed transcription factors, 
such as Ttf1, regulates gene transcription in Clara cell progenitors.     10
DISCUSSION  
 
  In this study we examined how Notch influences Clara cell fate specification in airway 
progenitors, and the influence of local microenvironment in generating diversity among Clara 
cell precursors during development.  We provide evidence that commitment to a Clara cell fate 
occurs much earlier than the expression of Ccsp and we identify expression of Scgb3a2 and 
Notch activation as early events in a program of Clara cell differentiation. Our in vitro assays 
show that Notch activation alone has a minimal effect in the transactivation of genes in Clara cell 
progenitors but is highly effective when combined with Ttf1. This context-dependency is of 
biological significance since genetic studies have shown that Ttf1 is critical for the overall 
induction of respiratory cell fate, including secretory Clara cells (27, 28).  
Ultrastructural studies of the developing airways show the pNEB microenvironment 
contains a distinct population of non-neuroendocrine,  non-ciliated cells (5). Here we report that 
this population of pNEB-associated epithelial can be distinguished in molecular terms by the 
expression of markers associated with Clara cells such as NICD, Scgb3a2, Upk3a, Cyp2f2 and 
Ccsp. Based on the marker that is most enriched and best distinguishes this population of cells, 
Upk3a, we undertook a lineage study to trace their fate in Upk3aCreER
T2; Rosa26 lacZ mice. We 
find that labeling at E15.5 results in lacZ expression in both Clara and ciliated cells of the adult 
airways at nearly the same proportion. Moreover, this lineage did not contribute to NE cells.  
Rawlins et al demonstrate that Scgb1a1CreER
TM; R26eYFP-expressing cells labeled at E18.5 
and examined in adult life contribute to both Clara and ciliated cells (2). Thus, our studies 
demonstrate that the Upk3a-expressing cells, despite expressing little Ccsp, exhibit the properties 
of a Scgb1a1-expressing Clara progenitor and implicate the pNEB microenvironment as a niche 
for Clara progenitors. It is likely that pNEBs are critical to specify or maintain the features of this 
subpopulation, however the identification of the NEB signals that mediate this process is beyond 
the scope of this work. Candidate signals present in NE cells potentially involved in these 
interactions include the Delta–like family of Notch ligands, or other currently uncharacterized 
Ascl1 targets (15). Interestingly, lineage analysis of the Scgb1a1-expressing cells at E18.5 also 
demonstrates that these labeled cells contribute significantly to the ciliated lineage in the first 
three months of post-natal life but not significantly thereafter. In contrast, lineage labeling of 
Scgb1a1-expressing cells in the adult period identifies a population that contributes to the 
ciliated lineage throughout adult life (2). An explanation for this disparity is that the population 
of Scgb1a1-expressing cells that were labeled in the embryonic period differs from the 
population labeled during the adult period. The identification of the Upk3a-lineage derived Clara 
progenitors, that remain uncommitted through embryonic development, supports this possibility. 
The spatial-temporal pattern of Scgb3a2 we describe in murine airways, including its 
enrichment in clusters in the pNEB microenvironment is highly reminiscent of the CCSP pattern 
reported in developing airways of humans (29). Although SCGB3A2 has been reported in human 
neonatal lungs, no information is available on its pattern at early developmental stages in humans 
(14). A number of human conditions are associated with abnormal increase in NE bodies, 
including NE cell hyperplasia of infancy (NEHI), Diffuse idiopathic pulmonary neuroendocrine 
cell hyperplasia (DIPNECH) and Bronchopulmonary dysplasia (BPD) The aberrant expansion of 
neuroepithelial cells in these conditions is likely to have a profound impact in the local 
microenvironment, as shown by the increase in the NEB-associated clusters of CCSP-expressing 
cells in BPD lungs (29). Thus, further studies to better understand the mechanisms and   11
consequences of the cellular interactions in this microenvironment have potentially high clinical 
significance. 
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MATERIALS AND METHODS 
 
Mouse strains and models 
 
Developmental and adult expression studies were performed on CD1 mice (Charles River). 
Generation and genotyping of Rbpjk conditional knockouts and Ascl1 knockouts mice have been 
described previously (8, 30). Constitutive activation of Notch signaling in the developing 
airways was induced by breeding Shh cre/+ males to Rosa26 Notch1-ICD IRES GFP females 
(Jackson Laboratory); embryos expressing Notch1-ICD could be identified either by GFP 
expression or by diminutive tails. For lineage tracing experiments, Upk3acreER
T2  (Jackson 
Laboratory) were bred to Rosa-26 LSL Lacz (Jackson Laboratory). For activation of β-
galactosidase expression in embryonic lungs, an intraperitoneal injection of Tamoxifen in corn 
oil (1 mg to 40g body weight) was administered to pregnant mice at E15.5. 
 
A detailed description of the reagents and methodologies  (ISH, IHC, Real time PCR, EMSA, 
Site-directed mutagenesis, DNA transfections and Luciferase reporter assays) used in this work 
can be found in Supplemental Materials. 
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FIGURE LEGENDS  
 
Figure 1: Spatial pattern of Notch activation in the developing airways.  (A-G) Labeling for 
cleaved Notch1 (NICD, red) and Ascl1 (green) indicates that Notch signaling is activated in the 
airways a few days earlier than Ccsp expression is detected (E15.5, 14) and that it is active in the 
NEB microenvironment from early stages. (A-B) Low levels of NICD were detected at E12.5 in 
trachea (Tr) and main bronchi (arrow) but no signal was detected in distal (dl) airways (shown at 
higher resolution B). Note strong NICD staining in the vasculature (V). (C-F) At E14.5 NICD 
labeling was more abundant in both the extrapulmonary airways (Tr in C, higher magnification 
in D) and proximal intrapulmonary airways (C, higher magnification in E), but no labeling was 
detected in distal airways (inset in C). (F) Clusters of strong NICD labeling in the proximal 
intrapulmonary airways at E14.5 are associated with clusters of Ascl1-expressing cells (arrows, 
airway outlined in white). Note the solitary Ascl1-expressing cells (arrowhead) further away are 
not associated with strong NICD labeling (F). (G) At E18.5 widespread labeling of NICD was 
detected in the in intrapulmonary airways including the NEB microenviroment (arrow). Lu=lung, 
L=lumen. Scale bar=10 um. 
 
Figure 2: Scgb3a2 expression correlates with NICD and identifies a distinct subpopulation 
of Clara-like progenitors associated with presumptive neuroepithelial bodies (pNEBs). (A-
D) Time-course of Scgb3a2 expression revealed a pattern similar to that of NICD (Fig. 1). 
Scgb3a2 was first detected in the trachea (Tr) at E12.5 (A) and in the intrapulmonary airways 
from E13.5-E14.5 (B-D). At E18.5 (D) Scgb3a2 expression was widespread and detected in both 
trachea (Tr) and terminal bronchiole (TB). Clusters of cells with strong signal could be discerned 
at E13.5-E14.5 (B, C, inset in C, arrows). (E) Colocalization of Scgb3a2 and NICD was readily 
observed in these cell clusters (arrows, lumen of the airway is indicated (L)).  (F) Double 
Scgb3a2 ISH/AsclI IHC revealed Scgb3a2-labeled clusters (F, right panel) juxtaposed to Ascl1-
expressing pNEBs. Inset in F shows that Scgb3a2-expressing cells (blue) have a clear nucleus 
not labeled by anti-Ascl1 (brown). No Ascl1-expressing cells were detected in the trachea (F, left 
panel). (G) High-resolution optical section showing that luminal Scgb3a2-expressing cells (ISH, 
red) could be distinguished from basal Ascl1-expressing cells (IHC, green). (H) Scgb3a2 and 
Ascl1 double labeling at E13.5 suggests that the formation of Ascl1-clusters (distal, arrows) 
precedes formation of Scgb3a2-Ascl1 dual clusters. (I-O) Analysis of Ccsp and Scgb3a2 
expression at E18.5 suggested that the cells associated with pNEBs may be a distinct 
subpopulation of Clara precursors. (I-K) Labeling of NICD (red, shown separately in J), Ccsp 
(white, shown separately in K) and Ascl1 (green) showed that the cells in the NEB 
microenvironment are NICD-positive but express low (arrow) to negligible levels of Ccsp at this 
stage. Cells with both NICD and Ccsp were abundant away from the NEB microenvironment (I). 
(L-O) Triple-labeling for Scgb3a2 (ISH, red, shown separately in M), Ccsp (ISH, green, shown 
separately in N) and Cgrp (IHC, blue, shown separately in O) at E18.5 showed that cells apposed 
to pNEBs express Scgb3a2 and low Ccsp (arrowhead) and some have Scgb3a2 but negligible 
Ccsp (arrow). Elsewhere Scgb3a2 and Ccsp signals are strong and colocalized (L).  
 
Figure 3: High levels of Uroplakin 3A (Upk3a) expression distinguishes secretory 
precursors in the pNEB microenvironment (A) Profiling of E18.5 control and Notch 
signaling-deficient (Rbpj
cnull) lungs identified known markers for secretory cells and implicated 
Upk3a as a novel marker. (B-C) ISH at E18.5 in control lungs revealed that Upk3a was highly   17
enriched in clusters of cells in the proximal airways (C, arrow) and expressed at low-levels in 
scattered cells in distal airways (C, bracket). No signal was detected along the airway axis in 
Rbpj
cnull airways (Tr, trachea). (D) qPCR analysis showed that Upk3a levels can be detected at 
E12.5 and increase throughout development. (E-F) Upk3a transcripts were detected by ISH from 
E14.5 onwards in cell clusters juxtaposed to Ascl1-expressing cells (E, F, boxed areas shown at 
higher magnification in insets).  Some expression away from clusters was detected from E16.5 
onwards (F, bracket). Upk3a expression was also detected in a few cells in the adult airways (G, 
arrow) frequently juxtaposed to Cgrp-expressing NEBs (inset). (H-K) Upk3a expression was 
perturbed in Ascl1 null (Ascl1
-/-) lungs.  Clusters of high Upk3a expression were detected in 
control at both E14.5 (H) and E18.5 (J) but not in mutant lungs at either time point (I,K, circled 
regions; note expression of Upk3A is detected in the esophagus in the mutant at E14.5 (I, eso)). 
Rare Upk3a-expressing cells (non-clustered) could still be seen in the E18.5 Ascl1 null mutant 
(K, inset).  (L) qRT-PCR analysis of Upk3a expression in Rbpjk-deficient and Ascl1 mutants at 
E14.5 and E18.5 showing that Upk3a expression is dependent on both Notch signaling and 
Ascl1. 
 
Figure 4: Lineage-analysis of Upk3a-expressing cells at E15.5 reveals that these cells are 
precursors of Clara and ciliated cells. (A) Experimental protocol for the induction and harvest 
of tissue from the Upk3acreER
T2 X Rosa26lacz. (B-E) Upk3a-lineage derived cells (blue) are 
distributed along the proximal-distal axis (airways counterstained with Fast Red) in clusters and 
as solitary cells (B, arrows). Regions 1, 2, 3 in B are shown at higher magnification in C-E. (F-
G) Double labeling of X-gal stained preparations for  PGP9.5 shows that Upk3a-lineage derived 
cells (arrows) are not in close association with NEBs (arrowheads) though rare examples of 
apposition are observed (G). Note that Lacz (arrow) and PGP9.5 (arrowhead) expressing cells 
are distinct from another. (H-I) Upk3a-expressing cells labeled at E15.5 contribute to Clara and 
Ciliated lineages in adults Double labeling of X-gal stained preparations for Ccsp (H) and 
βTubulin (I) demonstrate that these cells contribute to both Clara (H) and ciliated (I) lineages. (J-
K) Quantitation of the numbers of X-gal stained cells that co-label for Clara and ciliated markers 
at E18.5 (Ccsp, Foxj1, n=156 airways) and in adults (Ccsp, βTubulin, n=501 airways).  The 
Upk3a-lineage derived cells are mostly uncommitted to either Clara or ciliated fates at E18.5 but 
differentiate into these lineages in the peri-natal period (proportions of ciliated and clara cells in 
adults is shown graphically in K, mean+/-sem). See supplementary text for methods. 
 
 
Figure 5: Notch-dependent regulation of secretory cell-associated genes. (A-F) Analysis of 
Notch gain and loss-of-function in E14.5 airways in vivo (A,B) Disruption of Notch signaling  in 
Rbpj
cnull mutants disrupts expression of Scgb3a2 and Upk3a. Comparable segments of the 
intrapulmonary airways in A, B (encircled by grey lines) evidence negligible expression of both 
markers in Rbpj
cnull lungs. Residual low-level expression of Scgb3a2 was detected in the 
extrapulmonary airways of mutants only after prolonged ISH exposure (A, arrow). Double 
Scgb3a2 ISH/AsclI IHC shows that specification of pNEBs was unaffected in Rbpj
cnull mutants 
but no Scgb3a2  was detected in surrounding cells (A, inset, arrowhead). (C-F) Shhcre driven 
NICD perturbed lung architecture (compare distribution of Ttf1 in C, D) and resulted in 
widespread expression of Scgb3a2 and Upk3a. (G-H) In vitro analysis of the role of Notch 
signaling in the regulation of the Scgb3a2 promoter. (G) Schematic showing presumptive Rbpjk 
binding sites (high affinity site: red arrow; low affinity site: grey arrow) in the Scgb3a2 promoter   18
1 kb upstream to the transcription start site. Right panel: sequence of a -273 bp fragment of the 
Scgb3a2 promoter showing putative Rbpjk (red) and TTF1 (green)binding sites. (H) Validation 
of the predicted high affinity Rbpjk binding site in the Scgb3a2 promoter by EMSA. An anti-
Rbpjk antibody supershifted the labeled oligonucleotide containing the putative high affinity 
binding site (CTRL, Lane+ab). Note that the band that is supershifted by anti-Rbpjk was 
competed by co-incubation of the labeled oligonucleotide with an unlabeled CTRL 
oligonucleotide (cognate) but not competed by co-incubation with an unlabeled mutant 
oligonucleotide lacking the high affinity binding site (MUT, sequences shown below).  (I) 
Luciferase assay examining the sufficiency of NICD and Ttf1 in the transactivation of the 
Scgb3a2 promoter. NICD expression alone did not significantly transactivate the Scgb3a2 
promoter but co-expression of NICD and Ttf1 synergistically upregulated reporter expression. 
This synergistic upregulation was abolished when the high affinity Rbpjk binding site was 
mutated (-273mut, see G).  
 